Biotechnology
The Biotechnology industry has a total of 693 stocks, with a combined market cap of $1,322.69 billion and total revenue of $119.33 billion.
Market Cap
1,322.69B
Revenue
119.33B
Profits
-40.18B
PE Ratio
n/a
Profit Margin
-33.67%
Dividend Yield
0.02%
693 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | NVO | Novo Nordisk A/S | 460.13B | -0.02% | 2,055,360 | 30.42B |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 104.85B | -0.58% | 727,543 | 9.65B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 94.09B | -0.39% | 534,334 | 13.10B |
| 4 | MRNA | Moderna, Inc. | 37.92B | 0.67% | 5,204,646 | 9.12B |
| 5 | BNTX | BioNTech SE | 25.09B | -0.17% | 500,630 | 7.04B |
| 6 | ALNY | Alnylam Pharmaceuticals, Inc. | 24.02B | -2.20% | 270,075 | 1.72B |
| 7 | ARGX | argenx SE | 22.48B | 0.04% | 173,370 | 10.74M |
| 8 | GMAB | Genmab A/S | 20.80B | -0.34% | 241,408 | 2.41B |
| 9 | BGNE | BeiGene, Ltd. | 18.70B | 0.49% | 532,726 | 2.20B |
| 10 | BMRN | BioMarin Pharmaceutical Inc. | 18.16B | -0.73% | 630,336 | 2.31B |
| 11 | RPRX | Royalty Pharma plc | 16.90B | 0.46% | 1,402,860 | 2.32B |
| 12 | INCY | Incyte Corporation | 14.07B | 0.10% | 992,852 | 3.61B |
| 13 | TECH | Bio-Techne Corporation | 12.20B | -1.36% | 592,875 | 1.14B |
| 14 | KRTX | Karuna Therapeutics, Inc. | 11.99B | 0.07% | 1,114,188 | 5.93M |
| 15 | LEGN | Legend Biotech Corporation | 10.94B | 0.60% | 456,517 | - |
| 16 | UTHR | United Therapeutics Corporation | 10.33B | 0.30% | 258,346 | 2.20B |
| 17 | ROIV | Roivant Sciences Ltd. | 9.03B | -1.23% | 4,193,354 | 103.15M |
| 18 | SRPT | Sarepta Therapeutics, Inc. | 9.02B | -1.38% | 730,028 | 1.10B |
| 19 | IMGN | ImmunoGen, Inc. | 8.27B | -0.20% | 4,028,159 | 287.61M |
| 20 | CYTK | Cytokinetics, Incorporated | 8.19B | 0.30% | 6,322,036 | 7.82M |
| 21 | JAZZ | Jazz Pharmaceuticals plc | 7.74B | -0.29% | 694,502 | 3.79B |
| 22 | CERE | Cerevel Therapeutics Holdings, Inc. | 7.64B | -0.09% | 769,928 | - |
| 23 | EXEL | Exelixis, Inc. | 7.46B | -0.58% | 1,240,495 | 1.77B |
| 24 | IONS | Ionis Pharmaceuticals, Inc. | 7.26B | 0.18% | 1,104,389 | 615.03M |
| 25 | ASND | Ascendis Pharma A/S | 7.12B | -1.11% | 191,968 | 161.61M |
| 26 | APLS | Apellis Pharmaceuticals, Inc. | 7.09B | -4.73% | 1,629,044 | 272.88M |
| 27 | BBIO | BridgeBio Pharma, Inc. | 7.02B | -3.44% | 1,355,276 | 9.43M |
| 28 | IMVT | Immunovant, Inc. | 6.09B | -0.52% | 899,377 | - |
| 29 | PCVX | Vaxcyte, Inc. | 5.98B | -0.81% | 601,255 | - |
| 30 | BPMC | Blueprint Medicines Corporation | 5.61B | 0.97% | 876,004 | 216.20M |
| 31 | ACAD | ACADIA Pharmaceuticals Inc. | 5.14B | -0.24% | 1,299,292 | 631.89M |
| 32 | CRSP | CRISPR Therapeutics AG | 4.97B | -2.64% | 1,875,464 | 170.01M |
| 33 | HALO | Halozyme Therapeutics, Inc. | 4.88B | -0.51% | 933,749 | 780.71M |
| 34 | RVMD | Revolution Medicines, Inc. | 4.70B | -2.35% | 1,309,372 | 26.17M |
| 35 | ALKS | Alkermes plc | 4.63B | -0.50% | 1,244,203 | 1.59B |
| 36 | NUVL | Nuvalent, Inc. | 4.61B | -1.97% | 634,283 | - |
| 37 | MDGL | Madrigal Pharmaceuticals, Inc. | 4.57B | -1.12% | 313,001 | - |
| 38 | INSM | Insmed Incorporated | 4.43B | -2.36% | 766,285 | 280.82M |
| 39 | FOLD | Amicus Therapeutics, Inc. | 4.16B | -2.27% | 2,959,718 | 372.37M |
| 40 | MRTX | Mirati Therapeutics, Inc. | 4.12B | -0.27% | 1,834,559 | 38.19M |
| 41 | RARE | Ultragenyx Pharmaceutical Inc. | 3.93B | -0.93% | 573,413 | 410.21M |
| 42 | AXSM | Axsome Therapeutics, Inc. | 3.77B | -0.04% | 475,324 | 223.44M |
| 43 | RYZB | RayzeBio, Inc. | 3.73B | 0.81% | 895,422 | - |
| 44 | MLTX | MoonLake Immunotherapeutics | 3.62B | -1.77% | 487,404 | - |
| 45 | DNA | Ginkgo Bioworks Holdings, Inc. | 3.58B | -4.52% | 17,611,686 | 314.99M |
| 46 | KRYS | Krystal Biotech, Inc. | 3.50B | -2.90% | 268,338 | 8.56M |
| 47 | BHVN | Biohaven Pharmaceutical Holding Company Ltd. | 3.43B | -1.11% | 1,320,741 | - |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 3.40B | -0.52% | 658,015 | - |
| 49 | IMCR | Immunocore Holdings plc | 3.38B | -0.38% | 189,620 | 243.18M |
| 50 | IBRX | ImmunityBio, Inc. | 3.35B | -3.65% | 3,371,505 | 556.00K |
| 51 | CORT | Corcept Therapeutics Incorporated | 3.35B | -1.22% | 949,026 | 450.03M |
| 52 | ARWR | Arrowhead Pharmaceuticals, Inc. | 3.29B | -1.29% | 815,724 | 240.74M |
| 53 | FTRE | Fortrea Holdings Inc. | 3.10B | -0.94% | 387,231 | - |
| 54 | DNLI | Denali Therapeutics Inc. | 2.97B | -2.23% | 768,118 | 340.81M |
| 55 | NTLA | Intellia Therapeutics, Inc. | 2.73B | -4.03% | 1,253,768 | 51.77M |
| 56 | RYTM | Rhythm Pharmaceuticals, Inc. | 2.72B | -2.36% | 1,188,027 | 61.98M |
| 57 | RCKT | Rocket Pharmaceuticals, Inc. | 2.70B | -3.01% | 735,886 | - |
| 58 | ACLX | Arcellx, Inc. | 2.70B | -2.43% | 313,819 | 47.17M |
| 59 | ZLAB | Zai Lab Limited | 2.69B | 0.15% | 331,709 | 263.49M |
| 60 | GLPG | Galapagos NV | 2.68B | -0.15% | 72,533 | - |
| 61 | CBAY | CymaBay Therapeutics, Inc. | 2.68B | -1.54% | 1,867,970 | 31.02M |
| 62 | SWTX | SpringWorks Therapeutics, Inc. | 2.63B | -1.99% | 670,063 | - |
| 63 | NMRA | Neumora Therapeutics, Inc. | 2.60B | -0.53% | 223,393 | - |
| 64 | TGTX | TG Therapeutics, Inc. | 2.59B | -3.06% | 3,824,882 | 189.77M |
| 65 | CRNX | Crinetics Pharmaceuticals, Inc. | 2.38B | -0.48% | 652,971 | 4.72M |
| 66 | IDYA | IDEAYA Biosciences, Inc. | 2.29B | -0.70% | 759,107 | 23.48M |
| 67 | ARVN | Arvinas, Inc. | 2.26B | -1.98% | 597,535 | 167.20M |
| 68 | BEAM | Beam Therapeutics Inc. | 2.22B | -7.51% | 1,328,648 | 81.55M |
| 69 | CLDX | Celldex Therapeutics, Inc. | 2.17B | -0.85% | 574,566 | 4.37M |
| 70 | RXRX | Recursion Pharmaceuticals, Inc. | 2.13B | -7.07% | 4,605,990 | 47.36M |
| 71 | IOVA | Iovance Biotherapeutics, Inc. | 2.08B | -5.24% | 10,251,097 | 707.00K |
| 72 | PTCT | PTC Therapeutics, Inc. | 2.08B | -3.57% | 1,216,461 | 798.18M |
| 73 | VCYT | Veracyte, Inc. | 2.01B | -3.88% | 592,123 | 343.15M |
| 74 | PRTA | Prothena Corporation plc | 1.95B | -5.54% | 651,105 | 140.98M |
| 75 | HRMY | Harmony Biosciences Holdings, Inc. | 1.89B | -3.09% | 431,935 | 541.92M |
| 76 | VKTX | Viking Therapeutics, Inc. | 1.86B | -3.43% | 3,203,265 | - |
| 77 | SMMT | Summit Therapeutics Inc. | 1.82B | -7.77% | 1,383,339 | - |
| 78 | INBX | Inhibrx, Inc. | 1.80B | 8.76% | 1,448,392 | 440.00K |
| 79 | CPRX | Catalyst Pharmaceuticals, Inc. | 1.79B | -2.27% | 806,044 | 348.39M |
| 80 | AVTX | Avalo Therapeutics, Inc. | 1.75B | -23.10% | 358,876 | 2.25M |
| 81 | SNDX | Syndax Pharmaceuticals, Inc. | 1.74B | 0.09% | 794,736 | - |
| 82 | VCEL | Vericel Corporation | 1.70B | -1.14% | 343,215 | 185.21M |
| 83 | ABCL | AbCellera Biologics Inc. | 1.66B | -3.71% | 1,555,124 | 50.39M |
| 84 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.65B | -2.53% | 1,522,715 | 419.52M |
| 85 | VRNA | Verona Pharma plc | 1.59B | -1.39% | 762,745 | 458.00K |
| 86 | MRUS | Merus N.V. | 1.59B | -2.24% | 232,201 | 45.67M |
| 87 | MOR | MorphoSys AG | 1.49B | 0.51% | 714,264 | 321.80M |
| 88 | GPCR | Structure Therapeutics Inc. | 1.46B | 10.31% | 1,451,906 | - |
| 89 | ARDX | Ardelyx, Inc. | 1.44B | -3.43% | 6,697,984 | 134.27M |
| 90 | MORF | Morphic Holding, Inc. | 1.44B | -2.70% | 574,174 | 6.66M |
| 91 | RCUS | Arcus Biosciences, Inc. | 1.43B | -2.70% | 503,675 | 119.66M |
| 92 | APGE | Apogee Therapeutics, Inc. | 1.42B | -6.93% | 266,106 | - |
| 93 | KYMR | Kymera Therapeutics, Inc. | 1.41B | -5.07% | 886,183 | - |
| 94 | IRON | Disc Medicine, Inc. | 1.39B | 1.37% | 434,038 | - |
| 95 | MIRM | Mirum Pharmaceuticals, Inc. | 1.38B | -1.47% | 565,285 | 144.73M |
| 96 | RLAY | Relay Therapeutics, Inc. | 1.36B | -2.82% | 572,520 | 25.80M |
| 97 | SRRK | Scholar Rock Holding Corporation | 1.36B | -7.48% | 1,507,534 | - |
| 98 | VIR | Vir Biotechnology, Inc. | 1.35B | -2.24% | 724,202 | 118.80M |
| 99 | PTGX | Protagonist Therapeutics, Inc. | 1.32B | -0.86% | 326,362 | - |
| 100 | SAGE | Sage Therapeutics, Inc. | 1.30B | -1.77% | 506,616 | 11.35M |
| 101 | AKRO | Akero Therapeutics, Inc. | 1.30B | -2.79% | 1,294,413 | - |
| 102 | XNCR | Xencor, Inc. | 1.29B | -0.89% | 828,077 | 145.26M |
| 103 | AUPH | Aurinia Pharmaceuticals Inc. | 1.29B | -2.92% | 1,733,583 | 158.85M |
| 104 | DAWN | Day One Biopharmaceuticals, Inc. | 1.27B | -2.60% | 497,671 | - |
| 105 | BLTE | Belite Bio, Inc | 1.26B | -0.26% | 99,339 | - |
| 106 | LGND | Ligand Pharmaceuticals Incorporated | 1.25B | -0.58% | 83,262 | 130.26M |
| 107 | AGIO | Agios Pharmaceuticals, Inc. | 1.24B | -2.28% | 686,731 | 24.03M |
| 108 | KNSA | Kiniksa Pharmaceuticals, Ltd. | 1.23B | -1.74% | 913,594 | 248.75M |
| 109 | SLNO | Soleno Therapeutics, Inc. | 1.23B | 1.98% | 255,949 | - |
| 110 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.23B | -1.64% | 2,151,657 | 317.56M |
| 111 | KROS | Keros Therapeutics, Inc. | 1.19B | -3.14% | 177,628 | 8.00K |
| 112 | PHVS | Pharvaris N.V. | 1.15B | 0.39% | 173,924 | - |
| 113 | GERN | Geron Corporation | 1.15B | -1.86% | 4,268,033 | 317.00K |
| 114 | VRDN | Viridian Therapeutics, Inc. | 1.15B | -2.72% | 963,974 | 347.00K |
| 115 | AUTL | Autolus Therapeutics plc | 1.12B | -2.87% | 2,367,903 | 5.52M |
| 116 | ALPN | Alpine Immune Sciences, Inc. | 1.11B | -2.56% | 1,129,479 | 30.80M |
| 117 | VERV | Verve Therapeutics, Inc. | 1.09B | -6.76% | 1,470,649 | 7.63M |
| 118 | PLRX | Pliant Therapeutics, Inc. | 1.08B | -5.23% | 419,577 | 3.55M |
| 119 | ZNTL | Zentalis Pharmaceuticals, Inc. | 1.07B | -2.76% | 491,595 | - |
| 120 | KURA | Kura Oncology, Inc. | 1.07B | 0.49% | 671,500 | - |
| 121 | INVA | Innoviva, Inc. | 1.03B | -1.05% | 363,249 | 290.43M |
| 122 | ADMA | ADMA Biologics, Inc. | 1.02B | - | 1,725,768 | 234.29M |
| 123 | MDXG | MiMedx Group, Inc. | 1.02B | -1.46% | 526,307 | 309.02M |
| 124 | ETNB | 89bio, Inc. | 1.01B | -1.50% | 871,993 | - |
| 125 | TNGX | Tango Therapeutics, Inc. | 1.01B | -4.35% | 747,105 | 37.51M |
| 126 | AMLX | Amylyx Pharmaceuticals, Inc. | 993.86M | -0.20% | 936,701 | 294.22M |
| 127 | MNKD | MannKind Corporation | 981.25M | -1.62% | 1,697,051 | 176.55M |
| 128 | CABA | Cabaletta Bio, Inc. | 972.68M | -2.70% | 729,394 | - |
| 129 | GRCL | Gracell Biotechnologies Inc. | 969.59M | 1.11% | 1,742,222 | - |
| 130 | CRGX | CARGO Therapeutics, Inc. | 953.90M | 1.89% | 462,614 | - |
| 131 | SAVA | Cassava Sciences, Inc. | 949.34M | -1.19% | 805,083 | - |
| 132 | CVAC | CureVac N.V. | 942.55M | -1.64% | 652,505 | 45.62M |
| 133 | NAMS | NewAmsterdam Pharma Company N.V. | 919.56M | -2.27% | 15,611 | 14.90M |
| 134 | AMAM | Ambrx Biopharma Inc. | 899.26M | -1.79% | 790,651 | - |
| 135 | FDMT | 4D Molecular Therapeutics, Inc. | 866.19M | -3.57% | 215,391 | 21.99M |
| 136 | PRME | Prime Medicine, Inc. | 862.29M | -7.23% | 315,168 | - |
| 137 | RAPT | RAPT Therapeutics, Inc. | 854.75M | -2.40% | 276,481 | - |
| 138 | IMTX | Immatics N.V. | 846.59M | -2.50% | 315,426 | 75.72M |
| 139 | ARCT | Arcturus Therapeutics Holdings Inc. | 842.59M | -4.37% | 363,422 | 296.24M |
| 140 | EDIT | Editas Medicine, Inc. | 827.35M | -2.13% | 1,499,138 | 24.61M |
| 141 | LQDA | Liquidia Corporation | 822.82M | -0.33% | 788,490 | 18.32M |
| 142 | DYN | Dyne Therapeutics, Inc. | 816.30M | 1.06% | 726,213 | - |
| 143 | EYPT | EyePoint Pharmaceuticals, Inc. | 816.00M | -1.91% | 926,194 | 42.52M |
| 144 | SANA | Sana Biotechnology, Inc. | 804.30M | -6.21% | 1,396,630 | - |
| 145 | EXAI | Exscientia plc | 800.87M | -6.83% | 602,062 | 29.47M |
| 146 | RGNX | REGENXBIO Inc. | 789.66M | -3.18% | 619,576 | 99.37M |
| 147 | ICVX | Icosavax, Inc. | 789.42M | 0.51% | 268,198 | - |
| 148 | CNTA | Centessa Pharmaceuticals plc | 776.64M | -0.87% | 58,999 | - |
| 149 | RVNC | Revance Therapeutics, Inc. | 771.88M | -1.01% | 695,924 | 214.16M |
| 150 | OLMA | Olema Pharmaceuticals, Inc. | 768.42M | -3.17% | 903,034 | - |
| 151 | BCYC | Bicycle Therapeutics plc | 766.32M | -3.26% | 143,560 | 24.83M |
| 152 | HLVX | HilleVax, Inc. | 761.06M | -0.93% | 138,581 | - |
| 153 | AVXL | Anavex Life Sciences Corp. | 752.60M | -3.02% | 1,014,673 | - |
| 154 | ALXO | ALX Oncology Holdings Inc. | 741.80M | -2.58% | 728,994 | - |
| 155 | PHAR | Pharming Group N.V. | 732.73M | - | 454 | 232.68M |
| 156 | ZYME | Zymeworks Inc. | 727.32M | -2.90% | 300,990 | 461.58M |
| 157 | SLRN | Acelyrin, Inc. | 726.15M | -2.16% | 848,335 | - |
| 158 | VALN | Valneva SE | 719.47M | -0.01% | 5,951 | 237.46M |
| 159 | OABI | OmniAb, Inc. | 717.15M | 0.82% | 1,007,861 | 64.69M |
| 160 | ADPT | Adaptive Biotechnologies Corporation | 709.39M | -8.07% | 1,872,573 | 179.69M |
| 161 | PRTC | PureTech Health plc | 703.07M | 17.86% | 3,442 | 15.62M |
| 162 | FUSN | Fusion Pharmaceuticals Inc. | 695.82M | -0.41% | 999,612 | 2.21M |
| 163 | EWTX | Edgewise Therapeutics, Inc. | 694.27M | -4.87% | 835,950 | - |
| 164 | VERA | Vera Therapeutics, Inc. | 683.38M | -3.69% | 561,624 | - |
| 165 | TVTX | Travere Therapeutics, Inc. | 675.56M | -4.46% | 1,096,849 | 209.65M |
| 166 | ABVX | Abivax SA | 673.22M | -0.93% | 187,040 | - |
| 167 | ALEC | Alector, Inc. | 671.41M | -0.25% | 372,954 | 96.31M |
| 168 | RNA | Avidity Biosciences, Inc. | 670.62M | -3.00% | 554,856 | 10.14M |
| 169 | TARS | Tarsus Pharmaceuticals, Inc. | 670.37M | -2.32% | 678,440 | 14.37M |
| 170 | CALT | Calliditas Therapeutics AB (publ) | 667.60M | 1.88% | 18,405 | 105.88M |
| 171 | SVRA | Savara Inc. | 636.10M | -2.49% | 508,980 | - |
| 172 | SLN | Silence Therapeutics plc | 628.84M | 2.06% | 38,845 | 28.04M |
| 173 | AVTE | Aerovate Therapeutics, Inc. | 626.15M | -3.99% | 79,086 | - |
| 174 | ANTX | AN2 Therapeutics, Inc. | 609.40M | -1.96% | 113,305 | - |
| 175 | ALT | Altimmune, Inc. | 604.45M | -3.18% | 9,190,220 | 279.00K |
| 176 | WVE | Wave Life Sciences Ltd. | 601.01M | -0.20% | 710,450 | 85.49M |
| 177 | MGNX | MacroGenics, Inc. | 596.72M | -3.22% | 272,752 | 121.13M |
| 178 | TYRA | Tyra Biosciences, Inc. | 594.57M | -0.36% | 164,016 | - |
| 179 | MRNS | Marinus Pharmaceuticals, Inc. | 593.22M | -1.09% | 389,949 | 30.96M |
| 180 | ELVN | Enliven Therapeutics, Inc. | 570.37M | -5.01% | 140,612 | - |
| 181 | NVAX | Novavax, Inc. | 570.19M | -2.24% | 7,171,889 | 1.05B |
| 182 | ANAB | AnaptysBio, Inc. | 569.24M | -1.06% | 114,310 | 14.96M |
| 183 | TBPH | Theravance Biopharma, Inc. | 559.73M | -0.62% | 230,868 | 54.51M |
| 184 | ALLO | Allogene Therapeutics, Inc. | 540.17M | -1.83% | 1,854,223 | 186.00K |
| 185 | TRML | Tourmaline Bio, Inc. | 532.41M | -5.28% | 110,759 | - |
| 186 | SPRY | ARS Pharmaceuticals, Inc. | 526.06M | -2.66% | 379,191 | 1.35M |
| 187 | PHAT | Phathom Pharmaceuticals, Inc. | 522.72M | -0.11% | 375,839 | - |
| 188 | BMEA | Biomea Fusion, Inc. | 514.02M | -6.26% | 1,111,687 | - |
| 189 | CRBU | Caribou Biosciences, Inc. | 506.71M | -2.55% | 1,572,348 | 34.61M |
| 190 | COGT | Cogent Biosciences, Inc. | 506.41M | -2.81% | 851,394 | - |
| 191 | TRDA | Entrada Therapeutics, Inc. | 503.10M | -8.04% | 101,349 | 87.17M |
| 192 | ORIC | ORIC Pharmaceuticals, Inc. | 501.87M | - | 249,653 | - |
| 193 | NRIX | Nurix Therapeutics, Inc. | 500.56M | -3.64% | 428,106 | 68.61M |
| 194 | REPL | Replimune Group, Inc. | 497.87M | -1.86% | 764,074 | - |
| 195 | JANX | Janux Therapeutics, Inc. | 495.39M | -8.29% | 102,050 | 8.47M |
| 196 | ACIU | AC Immune SA | 493.75M | 3.31% | 242,836 | 1.09K |
| 197 | OCUL | Ocular Therapeutix, Inc. | 491.58M | -1.33% | 1,531,635 | 57.72M |
| 198 | LYEL | Lyell Immunopharma, Inc. | 488.63M | -8.06% | 1,900,559 | 48.50M |
| 199 | IGMS | IGM Biosciences, Inc. | 485.25M | -5.46% | 207,517 | 1.85M |
| 200 | LIAN | LianBio | 479.04M | 0.90% | 321,726 | - |
| 201 | URGN | UroGen Pharma Ltd. | 462.11M | -0.40% | 298,202 | 77.28M |
| 202 | IMNM | Immunome, Inc. | 457.21M | -0.28% | 439,671 | 10.19M |
| 203 | MGTX | MeiraGTx Holdings plc | 446.45M | -1.40% | 158,291 | - |
| 204 | CGEM | Cullinan Oncology, Inc. | 435.93M | -0.39% | 124,666 | - |
| 205 | THRD | Third Harmonic Bio, Inc. | 435.89M | -4.02% | 477,595 | - |
| 206 | AURA | Aura Biosciences, Inc. | 435.89M | -1.99% | 176,424 | - |
| 207 | IVVD | Invivyd, Inc. | 433.85M | 0.51% | 299,506 | - |
| 208 | HARP | Harpoon Therapeutics, Inc. | 427.46M | -0.61% | 105,226 | 37.34M |
| 209 | KALV | KalVista Pharmaceuticals, Inc. | 423.34M | 1.41% | 232,404 | - |
| 210 | CBUS | Cibus, Inc. | 421.91M | -2.39% | 95,434 | 756.00K |
| 211 | ABUS | Arbutus Biopharma Corporation | 419.24M | -1.57% | 584,619 | 22.24M |
| 212 | PROK | ProKidney Corp. | 419.07M | -2.20% | 1,146,664 | - |
| 213 | FULC | Fulcrum Therapeutics, Inc. | 417.30M | -1.60% | 1,315,980 | 2.62M |
| 214 | CDMO | Avid Bioservices, Inc. | 411.05M | -4.27% | 970,191 | 140.94M |
| 215 | OCS | Oculis Holding AG | 408.63M | -0.04% | 13,241 | - |
| 216 | TERN | Terns Pharmaceuticals, Inc. | 401.05M | -5.39% | 263,934 | - |
| 217 | ITOS | iTeos Therapeutics, Inc. | 391.85M | -0.82% | 122,259 | 66.50M |
| 218 | ABSI | Absci Corporation | 390.34M | -8.70% | 1,883,463 | 6.94M |
| 219 | LXRX | Lexicon Pharmaceuticals, Inc. | 374.74M | - | 2,804,683 | 531.00K |
| 220 | GNLX | Genelux Corporation | 374.31M | -13.47% | 191,532 | 238.00K |
| 221 | ORTX | Orchard Therapeutics plc | 373.86M | 0.18% | 67,322 | 21.84M |
| 222 | NAUT | Nautilus Biotechnology, Inc. | 373.59M | -9.12% | 213,129 | - |
| 223 | VYGR | Voyager Therapeutics, Inc. | 371.32M | -4.20% | 97,711 | 158.40M |
| 224 | CHRS | Coherus BioSciences, Inc. | 370.84M | 2.78% | 14,668,624 | 211.07M |
| 225 | FATE | Fate Therapeutics, Inc. | 368.77M | -5.08% | 1,657,253 | 106.21M |
| 226 | LXEO | Lexeo Therapeutics, Inc. | 357.58M | -7.77% | 63,596 | 654.00K |
| 227 | ANNX | Annexon, Inc. | 355.65M | -0.66% | 1,563,316 | - |
| 228 | AMRN | Amarin Corporation plc | 355.44M | -3.30% | 4,025,549 | 322.44M |
| 229 | MLYS | Mineralys Therapeutics, Inc. | 353.50M | 0.35% | 139,264 | - |
| 230 | CELC | Celcuity Inc. | 352.64M | -0.27% | 311,981 | - |
| 231 | STTK | Shattuck Labs, Inc. | 336.08M | -1.52% | 507,204 | 1.33M |
| 232 | CDT | Conduit Pharmaceuticals Inc. | 335.92M | -7.14% | 12,266 | - |
| 233 | PGEN | Precigen, Inc. | 333.55M | -4.96% | 1,406,346 | 6.76M |
| 234 | ANL | Adlai Nortye Ltd. | 331.73M | 0.78% | 3,843 | - |
| 235 | TSHA | Taysha Gene Therapies, Inc. | 330.92M | -0.56% | 845,697 | 14.35M |
| 236 | NUVB | Nuvation Bio Inc. | 330.61M | -1.31% | 605,660 | - |
| 237 | OBIO | Orchestra BioMed Holdings, Inc. | 326.34M | -5.29% | 25,964 | 3.60M |
| 238 | XERS | Xeris Biopharma Holdings, Inc. | 324.59M | -0.42% | 1,195,973 | 152.67M |
| 239 | NKTX | Nkarta, Inc. | 323.88M | 6.11% | 2,775,873 | - |
| 240 | QURE | uniQure N.V. | 323.68M | -0.88% | 955,486 | 111.90M |
| 241 | NBTX | Nanobiotix S.A. | 322.17M | -3.58% | 4,997 | 7.41M |
| 242 | ERAS | Erasca, Inc. | 321.82M | -3.18% | 838,276 | - |
| 243 | PSTX | Poseida Therapeutics, Inc. | 321.30M | -3.45% | 402,928 | 49.76M |
| 244 | AGEN | Agenus Inc. | 315.84M | 2.21% | 10,750,960 | 100.90M |
| 245 | VRCA | Verrica Pharmaceuticals Inc. | 307.91M | 0.41% | 431,383 | 3.20M |
| 246 | RPTX | Repare Therapeutics Inc. | 307.55M | -4.70% | 273,585 | 56.28M |
| 247 | ARQT | Arcutis Biotherapeutics, Inc. | 304.85M | -2.12% | 6,645,980 | 49.04M |
| 248 | GHRS | GH Research PLC | 301.72M | 4.69% | 94,557 | - |
| 249 | FENC | Fennec Pharmaceuticals Inc. | 298.84M | -3.36% | 154,372 | 13.05M |
| 250 | YMAB | Y-mAbs Therapeutics, Inc. | 297.50M | -7.71% | 104,658 | 92.90M |
| 251 | MREO | Mereo BioPharma Group plc | 296.59M | -0.86% | 447,563 | 9.02M |
| 252 | HUMA | Humacyte, Inc. | 294.15M | -4.38% | 368,028 | - |
| 253 | EPIX | ESSA Pharma Inc. | 291.34M | -6.91% | 118,467 | - |
| 254 | QSI | Quantum-Si incorporated | 284.87M | -11.45% | 1,239,715 | 682.00K |
| 255 | GLUE | Monte Rosa Therapeutics, Inc. | 282.96M | -4.72% | 122,968 | - |
| 256 | MRSN | Mersana Therapeutics, Inc. | 279.75M | -0.85% | 823,906 | 40.84M |
| 257 | ATXS | Astria Therapeutics, Inc. | 278.75M | -4.71% | 257,105 | - |
| 258 | CCCC | C4 Therapeutics, Inc. | 278.44M | -6.30% | 8,513,060 | 20.35M |
| 259 | LYRA | Lyra Therapeutics, Inc. | 275.43M | 5.43% | 122,157 | 1.42M |
| 260 | IMMP | Immutep Limited | 273.93M | -2.44% | 56,374 | 3.59M |
| 261 | FHTX | Foghorn Therapeutics Inc. | 272.30M | -4.59% | 47,042 | 32.57M |
| 262 | ZVRA | Zevra Therapeutics, Inc. | 271.73M | 14.91% | 897,280 | 16.56M |
| 263 | AEON | AEON Biopharma, Inc. | 267.55M | 2.56% | 18,445 | - |
| 264 | OPT | Opthea Limited | 265.49M | 0.91% | 28,000 | 385.28K |
| 265 | INZY | Inozyme Pharma, Inc. | 263.10M | -4.27% | 609,386 | - |
| 266 | STRO | Sutro Biopharma, Inc. | 261.49M | -1.61% | 583,172 | 48.64M |
| 267 | APLT | Applied Therapeutics, Inc. | 258.72M | 8.06% | 1,140,453 | 10.66M |
| 268 | HRTX | Heron Therapeutics, Inc. | 255.12M | -2.30% | 1,915,483 | 122.84M |
| 269 | AVIR | Atea Pharmaceuticals, Inc. | 254.48M | -1.61% | 210,624 | - |
| 270 | TCRX | TScan Therapeutics, Inc. | 253.89M | -2.51% | 125,476 | 16.93M |
| 271 | RIGL | Rigel Pharmaceuticals, Inc. | 252.84M | -7.05% | 730,669 | 132.37M |
| 272 | IVA | Inventiva S.A. | 243.27M | 1.03% | 21,338 | 22.04M |
| 273 | VNDA | Vanda Pharmaceuticals Inc. | 242.79M | -0.94% | 1,148,904 | 211.85M |
| 274 | ALLK | Allakos Inc. | 238.81M | -0.73% | 762,657 | - |
| 275 | STOK | Stoke Therapeutics, Inc. | 234.88M | -2.59% | 93,156 | 9.25M |
| 276 | PRLD | Prelude Therapeutics Incorporated | 234.13M | 2.89% | 99,801 | - |
| 277 | ATAI | Atai Life Sciences N.V. | 234.07M | -5.37% | 979,861 | 334.00K |
| 278 | AKBA | Akebia Therapeutics, Inc. | 233.60M | -3.13% | 2,126,420 | 193.61M |
| 279 | OVID | Ovid Therapeutics Inc. | 227.59M | -3.74% | 123,842 | 296.41K |
| 280 | IPHA | Innate Pharma S.A. | 225.75M | 2.00% | 17,298 | 57.45M |
| 281 | SCPH | scPharmaceuticals Inc. | 224.85M | -1.95% | 291,390 | 7.50M |
| 282 | ABOS | Acumen Pharmaceuticals, Inc. | 222.38M | 0.26% | 455,009 | - |
| 283 | CLLS | Cellectis S.A. | 220.99M | -9.14% | 133,705 | 24.41M |
| 284 | TNYA | Tenaya Therapeutics, Inc. | 220.68M | -4.42% | 474,468 | - |
| 285 | TSVT | 2seventy bio, Inc. | 216.13M | -6.77% | 1,159,661 | 145.88M |
| 286 | IMRX | Immuneering Corporation | 215.13M | -5.77% | 41,914 | 455.00 |
| 287 | CDXS | Codexis, Inc. | 212.98M | -2.56% | 687,503 | 73.96M |
| 288 | XOMA | XOMA Corporation | 212.52M | -2.32% | 32,869 | 4.41M |
| 289 | RENB | Renovaro Biosciences Inc. | 211.43M | -0.63% | 27,697 | - |
| 290 | DRTS | Alpha Tau Medical Ltd. | 209.11M | 6.36% | 80,693 | - |
| 291 | ZURA | Zura Bio Limited | 209.00M | -2.71% | 182,676 | - |
| 292 | ALDX | Aldeyra Therapeutics, Inc. | 206.47M | -2.77% | 900,067 | - |
| 293 | CRMD | CorMedix Inc. | 206.09M | -2.84% | 419,242 | 29.70K |
| 294 | PBYI | Puma Biotechnology, Inc. | 205.98M | -0.46% | 221,230 | 229.13M |
| 295 | GOSS | Gossamer Bio, Inc. | 205.69M | 3.38% | 738,933 | - |
| 296 | VSTM | Verastem, Inc. | 205.68M | -1.57% | 55,841 | - |
| 297 | OMER | Omeros Corporation | 205.57M | -7.10% | 953,674 | - |
| 298 | INMB | INmune Bio, Inc. | 202.92M | -1.66% | 83,597 | 224.00K |
| 299 | SYRS | Syros Pharmaceuticals, Inc. | 202.59M | 8.19% | 502,210 | 8.80M |
| 300 | MESO | Mesoblast Limited | 201.53M | 1.85% | 244,865 | 7.50M |
| 301 | LRMR | Larimar Therapeutics, Inc. | 199.77M | -1.09% | 46,226 | - |
| 302 | CMPX | Compass Therapeutics, Inc. | 198.88M | 4.70% | 335,946 | - |
| 303 | IPSC | Century Therapeutics, Inc. | 198.65M | 7.10% | 182,232 | 2.49M |
| 304 | ENTA | Enanta Pharmaceuticals, Inc. | 198.16M | -3.59% | 175,703 | 79.20M |
| 305 | DBVT | DBV Technologies S.A. | 195.57M | -3.78% | 133,602 | 5.55M |
| 306 | GRTS | Gritstone bio, Inc. | 194.50M | -0.97% | 930,267 | 10.23M |
| 307 | MACK | Merrimack Pharmaceuticals, Inc. | 192.04M | 0.60% | 55,775 | - |
| 308 | ANVS | Annovis Bio, Inc. | 191.91M | -4.40% | 369,607 | - |
| 309 | GNFT | Genfit S.A. | 191.39M | - | 4,798 | 32.69M |
| 310 | PRAX | Praxis Precision Medicines, Inc. | 190.94M | 4.06% | 90,785 | 1.93M |
| 311 | LCTX | Lineage Cell Therapeutics, Inc. | 190.74M | -5.22% | 998,511 | 8.77M |
| 312 | MCRB | Seres Therapeutics, Inc. | 180.96M | - | 2,787,497 | 127.24M |
| 313 | THRX | Theseus Pharmaceuticals, Inc. | 176.60M | -3.11% | 197,630 | - |
| 314 | CGEN | Compugen Ltd. | 174.89M | 11.24% | 1,651,631 | 7.50M |
| 315 | CYBN | Cybin Inc. | 166.42M | 1.49% | 1,642,158 | - |
| 316 | RANI | Rani Therapeutics Holdings, Inc. | 165.99M | -0.90% | 57,574 | - |
| 317 | OMGA | Omega Therapeutics, Inc. | 165.98M | -2.90% | 87,824 | 2.84M |
| 318 | PEPG | PepGen Inc. | 161.93M | -3.55% | 80,122 | - |
| 319 | PRQR | ProQR Therapeutics N.V. | 160.02M | 0.51% | 157,266 | 4.92M |
| 320 | KOD | Kodiak Sciences Inc. | 159.52M | -6.17% | 352,882 | - |
| 321 | MOLN | Molecular Partners AG | 159.30M | -2.79% | 3,057 | 9.46M |
| 322 | PMVP | PMV Pharmaceuticals, Inc. | 158.59M | -2.21% | 277,259 | - |
| 323 | GTHX | G1 Therapeutics, Inc. | 158.12M | 0.66% | 833,575 | 77.89M |
| 324 | IMAB | I-Mab | 156.98M | 3.83% | 885,446 | -35.05M |
| 325 | ADAP | Adaptimmune Therapeutics plc | 156.61M | 14.91% | 1,291,957 | 71.08M |
| 326 | PDSB | PDS Biotechnology Corporation | 154.61M | -2.55% | 583,587 | - |
| 327 | DNTH | Dianthus Therapeutics, Inc. | 154.11M | 2.67% | 8,756 | 924.00K |
| 328 | VOR | Vor Biopharma Inc. | 152.56M | -13.46% | 209,055 | - |
| 329 | GLYC | GlycoMimetics, Inc. | 151.97M | -5.98% | 152,528 | - |
| 330 | GRPH | Graphite Bio, Inc. | 151.95M | -1.50% | 134,614 | - |
| 331 | BLUE | bluebird bio, Inc. | 150.98M | -2.13% | 7,591,945 | 21.73M |
| 332 | CAPR | Capricor Therapeutics, Inc. | 150.58M | -1.11% | 162,195 | 14.05M |
| 333 | DSGN | Design Therapeutics, Inc. | 148.41M | -3.99% | 246,069 | - |
| 334 | ADCT | ADC Therapeutics SA | 147.81M | 4.40% | 457,832 | 122.57M |
| 335 | OCGN | Ocugen, Inc. | 147.49M | 1.82% | 5,906,256 | - |
| 336 | MNMD | Mind Medicine (MindMed) Inc. | 146.75M | -3.68% | 494,179 | - |
| 337 | VTYX | Ventyx Biosciences, Inc. | 145.66M | -4.63% | 2,021,701 | - |
| 338 | BDTX | Black Diamond Therapeutics, Inc. | 145.09M | -7.26% | 453,482 | - |
| 339 | NVCT | Nuvectis Pharma, Inc. | 144.36M | -2.68% | 19,024 | - |
| 340 | LBPH | Longboard Pharmaceuticals, Inc. | 143.86M | -2.74% | 123,954 | - |
| 341 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 143.78M | 2.79% | 395,322 | - |
| 342 | BRNS | Barinthus Biotherapeutics plc | 142.31M | 1.93% | 12,517 | 7.26M |
| 343 | XFOR | X4 Pharmaceuticals, Inc. | 140.27M | -2.97% | 1,184,354 | - |
| 344 | HOWL | Werewolf Therapeutics, Inc. | 139.70M | -6.99% | 294,438 | 25.73M |
| 345 | ATNM | Actinium Pharmaceuticals, Inc. | 139.26M | 1.60% | 285,523 | - |
| 346 | INO | Inovio Pharmaceuticals, Inc. | 139.22M | -1.90% | 1,524,270 | 854.03K |
| 347 | VTGN | VistaGen Therapeutics, Inc. | 138.90M | -1.91% | 325,972 | 810.50K |
| 348 | CVM | CEL-SCI Corporation | 135.95M | -4.23% | 616,552 | - |
| 349 | IMMX | Immix Biopharma, Inc. | 135.69M | 3.13% | 165,777 | - |
| 350 | RNAC | Cartesian Therapeutics Inc. | 135.20M | -6.84% | 695,971 | 34.53M |
| 351 | GLSI | Greenwich LifeSciences, Inc. | 135.16M | -2.41% | 24,100 | - |
| 352 | PLX | Protalix BioTherapeutics, Inc. | 129.85M | -1.11% | 577,665 | 63.63M |
| 353 | RLMD | Relmada Therapeutics, Inc. | 124.61M | 9.23% | 292,133 | - |
| 354 | ABEO | Abeona Therapeutics Inc. | 124.11M | -2.53% | 144,981 | 3.57M |
| 355 | SGMT | Sagimet Biosciences Inc. | 124.10M | -7.98% | 153,445 | 2.00M |
| 356 | SLDB | Solid Biosciences Inc. | 123.89M | -8.77% | 73,647 | - |
| 357 | IOBT | IO Biotech, Inc. | 123.86M | -3.59% | 144,073 | - |
| 358 | SEER | Seer, Inc. | 123.82M | -1.52% | 522,413 | 16.83M |
| 359 | XBIT | XBiotech Inc. | 121.75M | 0.76% | 9,764 | 300.00K |
| 360 | VIGL | Vigil Neuroscience, Inc. | 121.25M | -8.40% | 73,407 | - |
| 361 | ANIX | Anixa Biosciences, Inc. | 120.55M | -0.26% | 97,607 | 210.00K |
| 362 | CTXR | Citius Pharmaceuticals, Inc. | 120.18M | -1.97% | 823,817 | - |
| 363 | SPRB | Spruce Biosciences, Inc. | 119.28M | 2.81% | 211,202 | 7.20M |
| 364 | CUE | Cue Biopharma, Inc. | 119.13M | -7.04% | 765,082 | 3.82M |
| 365 | CARM | Carisma Therapeutics, Inc. | 118.25M | -4.56% | 149,598 | 10.63M |
| 366 | BCAB | BioAtla, Inc. | 117.60M | -12.46% | 813,540 | - |
| 367 | INTS | Intensity Therapeutics, Inc. | 117.49M | 8.48% | 163,955 | - |
| 368 | ARMP | Armata Pharmaceuticals, Inc. | 117.11M | 1.25% | 86,789 | 4.05M |
| 369 | BLRX | BioLineRx Ltd. | 113.73M | 0.64% | 239,030 | - |
| 370 | ETON | Eton Pharmaceuticals, Inc. | 112.36M | -4.78% | 128,483 | 33.48M |
| 371 | KNTE | Kinnate Biopharma Inc. | 111.66M | -2.87% | 329,722 | - |
| 372 | ATOS | Atossa Therapeutics, Inc. | 110.27M | -9.85% | 1,585,550 | - |
| 373 | CYT | Cyteir Therapeutics, Inc. | 109.43M | - | 12,171 | - |
| 374 | GBIO | Generation Bio Co. | 109.03M | -9.34% | 1,084,090 | 3.03M |
| 375 | ACRV | Acrivon Therapeutics, Inc. | 108.75M | -1.20% | 22,098 | - |
| 376 | DMAC | DiaMedica Therapeutics Inc. | 107.79M | -2.41% | 37,096 | - |
| 377 | NKTR | Nektar Therapeutics | 107.79M | 2.36% | 1,583,329 | 88.26M |
| 378 | VAXX | Vaxxinity, Inc. | 107.73M | -8.09% | 339,292 | - |
| 379 | CDXC | ChromaDex Corporation | 107.43M | -3.38% | 70,965 | 83.37M |
| 380 | LPTX | Leap Therapeutics, Inc. | 105.97M | -13.28% | 352,883 | - |
| 381 | CTMX | CytomX Therapeutics, Inc. | 103.83M | 0.32% | 741,158 | 75.55M |
| 382 | GALT | Galectin Therapeutics Inc. | 102.67M | 1.84% | 154,263 | - |
| 383 | OTLK | Outlook Therapeutics, Inc. | 102.54M | -7.66% | 2,501,251 | - |
| 384 | VERU | Veru Inc. | 100.44M | -5.08% | 1,543,325 | 16.30M |
| 385 | ONCY | Oncolytics Biotech Inc. | 99.09M | -0.74% | 350,221 | - |
| 386 | KPTI | Karyopharm Therapeutics Inc. | 99.07M | -6.31% | 1,013,681 | 145.87M |
| 387 | SGMO | Sangamo Therapeutics, Inc. | 96.35M | -9.30% | 1,838,071 | 201.42M |
| 388 | IFRX | InflaRx N.V. | 95.98M | -1.81% | 239,027 | 60.80K |
| 389 | CASI | CASI Pharmaceuticals, Inc. | 95.38M | -0.42% | 76,100 | 42.26M |
| 390 | IKNA | Ikena Oncology, Inc. | 95.07M | -2.48% | 85,019 | 13.95M |
| 391 | MDWD | MediWound Ltd. | 93.76M | -1.07% | 19,235 | 24.97M |
| 392 | BCTX | BriaCell Therapeutics Corp. | 93.49M | 6.95% | 192,247 | - |
| 393 | AFMD | Affimed N.V. | 93.34M | 15.98% | 2,092,627 | 20.23M |
| 394 | ORMP | Oramed Pharmaceuticals Inc. | 93.18M | -1.28% | 230,842 | 2.02M |
| 395 | ATHA | Athira Pharma, Inc. | 92.47M | -1.22% | 443,812 | - |
| 396 | MLEC | Moolec Science SA | 92.41M | 0.82% | 230 | 905.05K |
| 397 | EYEN | Eyenovia, Inc. | 91.77M | - | 271,009 | 1.20K |
| 398 | RLYB | Rallybio Corporation | 90.33M | -4.40% | 108,234 | - |
| 399 | GNTA | Genenta Science S.p.A. | 90.17M | 3.13% | 1,555 | - |
| 400 | JSPR | Jasper Therapeutics, Inc. | 88.03M | 9.90% | 1,517,328 | - |
| 401 | CTCX | Carmell Therapeutics Corporation | 87.94M | -5.84% | 5,066 | 25.65M |
| 402 | CLDI | Calidi Biotherapeutics Inc. | 87.25M | 7.09% | 335,157 | 45.00K |
| 403 | ACHV | Achieve Life Sciences, Inc. | 87.20M | -0.96% | 70,734 | - |
| 404 | FGEN | FibroGen, Inc. | 87.16M | -2.49% | 997,866 | 154.98M |
| 405 | SYRE | Spyre Therapeutics Inc. | 87.10M | 4.98% | 111,015 | 1.05M |
| 406 | VXRT | Vaxart, Inc. | 87.09M | 0.53% | 1,466,492 | 4.16M |
| 407 | BTAI | BioXcel Therapeutics, Inc. | 86.35M | -1.67% | 565,337 | 1.24M |
| 408 | APLM | Apollomics, Inc. | 86.35M | 3.86% | 265,390 | - |
| 409 | CRVS | Corvus Pharmaceuticals, Inc. | 86.31M | 1.15% | 136,224 | - |
| 410 | TRVI | Trevi Therapeutics, Inc. | 85.57M | -3.60% | 213,192 | - |
| 411 | CMRX | Chimerix, Inc. | 85.56M | 4.90% | 900,010 | 1.13M |
| 412 | TPST | Tempest Therapeutics, Inc. | 84.69M | -3.51% | 692,156 | - |
| 413 | LIFE | aTyr Pharma, Inc. | 82.57M | -4.08% | 277,736 | 10.74M |
| 414 | ACET | Adicet Bio, Inc. | 81.58M | 8.62% | 624,769 | - |
| 415 | ADAG | Adagene Inc. | 80.62M | 8.51% | 34,630 | 22.67M |
| 416 | ELTX | Elicio Therapeutics, Inc. | 80.11M | 0.97% | 71,725 | - |
| 417 | PYXS | Pyxis Oncology, Inc. | 79.73M | 0.56% | 230,529 | - |
| 418 | SPRO | Spero Therapeutics, Inc. | 77.91M | 0.68% | 183,046 | 77.70M |
| 419 | ALVR | AlloVir, Inc. | 77.54M | -0.03% | 2,597,900 | - |
| 420 | CSBR | Champions Oncology, Inc. | 76.40M | 3.88% | 18,857 | 49.98M |
| 421 | ADVM | Adverum Biotechnologies, Inc. | 76.05M | -0.42% | 365,922 | 3.60M |
| 422 | CRIS | Curis, Inc. | 75.15M | -8.21% | 53,573 | 10.21M |
| 423 | ELYM | Eliem Therapeutics, Inc. | 74.45M | -1.10% | 59,561 | - |
| 424 | COYA | Coya Therapeutics, Inc. | 73.71M | -1.20% | 87,324 | - |
| 425 | MNOV | MediciNova, Inc. | 73.57M | 6.38% | 157,747 | 1.00M |
| 426 | CLGN | CollPlant Biotechnologies Ltd. | 73.18M | 0.16% | 31,651 | 10.72M |
| 427 | CLSD | Clearside Biomedical, Inc. | 73.02M | - | 349,597 | 2.21M |
| 428 | KRON | Kronos Bio, Inc. | 72.90M | 0.81% | 282,956 | 4.00M |
| 429 | CDTX | Cidara Therapeutics, Inc. | 71.80M | -1.98% | 602,729 | 56.54M |
| 430 | NGM | NGM Biopharmaceuticals, Inc. | 71.05M | -4.56% | 800,561 | - |
| 431 | KZR | Kezar Life Sciences, Inc. | 68.87M | -2.90% | 437,024 | 7.00M |
| 432 | OCUP | Ocuphire Pharma, Inc. | 68.14M | -2.90% | 308,823 | 57.21M |
| 433 | IMUX | Immunic, Inc. | 67.72M | -3.23% | 327,734 | - |
| 434 | GANX | Gain Therapeutics, Inc. | 66.79M | 11.05% | 284,960 | 55.18K |
| 435 | CRDF | Cardiff Oncology, Inc. | 66.12M | 2.07% | 179,522 | 460.00K |
| 436 | HOOK | HOOKIPA Pharma Inc. | 66.06M | 8.01% | 1,254,338 | 20.55M |
| 437 | SABS | SAB Biotherapeutics, Inc. | 63.43M | -0.51% | 39,357 | 4.09M |
| 438 | ANEB | Anebulo Pharmaceuticals, Inc. | 62.03M | -1.63% | 154,672 | - |
| 439 | CNTB | Connect Biopharma Holdings Limited | 61.09M | 7.27% | 506,790 | - |
| 440 | AVRO | AVROBIO, Inc. | 60.62M | -4.23% | 157,811 | - |
| 441 | NKGN | NKGen Biotech, Inc. | 60.19M | -10.42% | 154,418 | 77.00K |
| 442 | TSBX | Turnstone Biologics Corp. | 58.77M | -9.11% | 33,898 | 81.89M |
| 443 | OKYO | OKYO Pharma Limited | 57.27M | -6.84% | 18,203 | - |
| 444 | GDTC | CytoMed Therapeutics Limited | 56.49M | -5.77% | 133,239 | 363.91K |
| 445 | TLSA | Tiziana Life Sciences Ltd | 56.33M | -1.55% | 70,994 | - |
| 446 | CGTX | Cognition Therapeutics, Inc. | 56.27M | -1.60% | 74,525 | - |
| 447 | MIST | Milestone Pharmaceuticals Inc. | 55.92M | -5.65% | 789,542 | 4.50M |
| 448 | PASG | Passage Bio, Inc. | 55.37M | - | 541,400 | - |
| 449 | GMDA | Gamida Cell Ltd. | 54.74M | 2.64% | 6,886,647 | 673.00K |
| 450 | PTN | Palatin Technologies, Inc. | 54.67M | 2.84% | 471,000 | 6.09M |
| 451 | RAIN | Rain Therapeutics Inc. | 54.22M | - | 447,650 | - |
| 452 | ASMB | Assembly Biosciences, Inc. | 53.96M | 1.88% | 370,584 | - |
| 453 | RPHM | Reneo Pharmaceuticals, Inc. | 53.30M | - | 1,999,135 | - |
| 454 | ACXP | Acurx Pharmaceuticals, Inc. | 52.73M | -3.53% | 105,583 | - |
| 455 | CKPT | Checkpoint Therapeutics, Inc. | 52.27M | 1.33% | 1,032,913 | 171.00K |
| 456 | ATRA | Atara Biotherapeutics, Inc. | 52.27M | -6.51% | 2,563,090 | 4.54M |
| 457 | CDIO | Cardio Diagnostics Holdings, Inc. | 51.09M | -4.23% | 1,400,723 | 12.71K |
| 458 | ENLV | Enlivex Therapeutics Ltd. | 50.19M | 4.65% | 167,536 | - |
| 459 | ALGS | Aligos Therapeutics, Inc. | 49.75M | 1.05% | 1,749,365 | 16.39M |
| 460 | TIL | Instil Bio, Inc. | 49.56M | -0.52% | 58,668 | - |
| 461 | AADI | Aadi Bioscience, Inc. | 49.54M | -3.81% | 647,375 | 23.26M |
| 462 | MRKR | Marker Therapeutics, Inc. | 48.89M | -4.35% | 112,845 | 9.06M |
| 463 | BIVI | BioVie Inc. | 47.56M | 3.70% | 490,268 | - |
| 464 | YS | YS Biopharma Co., Ltd. | 47.55M | 2.61% | 194,993 | - |
| 465 | CELU | Celularity Inc. | 47.24M | 32.30% | 3,655,640 | 15.14M |
| 466 | MTNB | Matinas BioPharma Holdings, Inc. | 46.97M | -4.55% | 1,738,694 | 4.28M |
| 467 | LTRN | Lantern Pharma Inc. | 46.52M | -2.51% | 43,281 | - |
| 468 | DYAI | Dyadic International, Inc. | 46.39M | 2.55% | 34,439 | 2.96M |
| 469 | NGNE | Neurogene Inc | 45.50M | 12.81% | 364,892 | - |
| 470 | QNCX | Quince Therapeutics, Inc. | 45.01M | -4.55% | 84,820 | - |
| 471 | IPA | ImmunoPrecise Antibodies Ltd. | 45.00M | 0.59% | 134,892 | 16.52M |
| 472 | FBIO | Fortress Biotech, Inc. | 44.63M | -22.62% | 2,184,451 | 80.97M |
| 473 | DTIL | Precision BioSciences, Inc. | 44.50M | -1.32% | 1,875,091 | 52.29M |
| 474 | INAB | IN8bio, Inc. | 44.15M | -2.82% | 127,350 | - |
| 475 | HCWB | HCW Biologics Inc. | 44.07M | 2.08% | 18,542 | 576.02K |
| 476 | ELDN | Eledon Pharmaceuticals, Inc. | 43.56M | -3.23% | 49,670 | - |
| 477 | CRVO | CervoMed Inc. | 43.30M | 20.73% | 24,801 | 1.53M |
| 478 | NERV | Minerva Neurosciences, Inc. | 43.01M | -4.65% | 12,250 | - |
| 479 | BOLT | Bolt Biotherapeutics, Inc. | 42.52M | 4.67% | 628,255 | 7.20M |
| 480 | CADL | Candel Therapeutics, Inc. | 42.51M | 5.76% | 102,500 | - |
| 481 | EVGN | Evogene Ltd. | 42.46M | -0.01% | 125,562 | 5.72M |
| 482 | XRTX | XORTX Therapeutics Inc. | 41.56M | 14.36% | 26,829 | - |
| 483 | LVTX | LAVA Therapeutics N.V. | 41.54M | 0.64% | 40,649 | 9.63M |
| 484 | CARA | Cara Therapeutics, Inc. | 40.48M | -3.15% | 1,412,982 | 21.23M |
| 485 | ICCC | ImmuCell Corporation | 39.45M | 3.67% | 10,395 | 16.29M |
| 486 | RZLT | Rezolute, Inc. | 39.33M | 0.37% | 23,323 | - |
| 487 | NRXP | NRx Pharmaceuticals, Inc. | 39.18M | -0.86% | 480,134 | - |
| 488 | ESLA | Estrella Immunopharma, Inc. | 39.07M | -4.31% | 49,097 | - |
| 489 | MEIP | MEI Pharma, Inc. | 38.64M | -2.68% | 38,037 | 105.38M |
| 490 | CLNN | Clene Inc. | 38.09M | 5.93% | 2,842,266 | 718.00K |
| 491 | KA | Kineta, Inc. | 37.73M | -4.22% | 45,532 | 3.31M |
| 492 | INKT | MiNK Therapeutics, Inc. | 36.94M | -2.73% | 55,423 | - |
| 493 | BIOR | Biora Therapeutics, Inc. | 36.73M | -3.57% | 553,814 | 18.00K |
| 494 | ACHL | Achilles Therapeutics plc | 36.26M | 2.18% | 458,633 | - |
| 495 | PRTG | Portage Biotech Inc. | 36.00M | 12.35% | 28,076 | - |
| 496 | KRRO | Korro Bio Inc. | 35.40M | -2.50% | 15,106 | - |
| 497 | SYBX | Synlogic, Inc. | 35.38M | 11.59% | 73,428 | 708.00K |
| 498 | FIXX | Homology Medicines, Inc. | 35.22M | 5.67% | 517,724 | 1.96M |
| 499 | BYSI | BeyondSpring Inc. | 35.03M | 2.51% | 40,351 | 1.35M |
| 500 | LGVN | Longeveron Inc. | 34.15M | -2.16% | 91,398 | 767.00K |
| 501 | CLRB | Cellectar Biosciences, Inc. | 34.04M | 11.24% | 833,886 | - |
| 502 | SLS | SELLAS Life Sciences Group, Inc. | 33.99M | -2.75% | 497,160 | - |
| 503 | VYNE | VYNE Therapeutics Inc. | 32.52M | -6.80% | 94,244 | 354.00K |
| 504 | UBX | Unity Biotechnology, Inc. | 32.40M | 1.05% | 636,542 | - |
| 505 | NXTC | NextCure, Inc. | 31.81M | -0.87% | 31,065 | - |
| 506 | ELAB | Elevai Labs, Inc. | 31.68M | 2.13% | 9,818 | 1.03M |
| 507 | ONCT | Oncternal Therapeutics, Inc. | 31.62M | 9.88% | 367,842 | 659.00K |
| 508 | UNCY | Unicycive Therapeutics, Inc. | 31.39M | -0.82% | 623,546 | - |
| 509 | SLGL | Sol-Gel Technologies Ltd. | 30.73M | -11.60% | 43,535 | 1.67M |
| 510 | DARE | Daré Bioscience, Inc. | 30.46M | -5.10% | 790,829 | 1.00M |
| 511 | EFTR | eFFECTOR Therapeutics, Inc. | 30.20M | 1.65% | 1,829,426 | 675.00K |
| 512 | VTVT | vTv Therapeutics Inc. | 30.07M | 25.14% | 111,678 | 9.00K |
| 513 | FBRX | Forte Biosciences, Inc. | 29.86M | 8.12% | 75,509 | - |
| 514 | SNTI | Senti Biosciences, Inc. | 29.40M | 11.68% | 813,354 | 2.62M |
| 515 | FRLN | Freeline Therapeutics Holdings plc | 27.76M | - | 9,516 | 622.00K |
| 516 | ACST | Acasti Pharma Inc. | 27.16M | -0.69% | 28,528 | - |
| 517 | PHXM | PHAXIAM Therapeutics S.A. | 26.97M | -9.39% | 3,818 | 6.56M |
| 518 | COEP | Coeptis Therapeutics, Inc. | 26.74M | 4.38% | 130,919 | - |
| 519 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 26.72M | -1.95% | 19,847 | - |
| 520 | ITRM | Iterum Therapeutics plc | 26.43M | -1.50% | 145,357 | - |
| 521 | RGLS | Regulus Therapeutics Inc. | 25.89M | 1.59% | 35,449 | - |
| 522 | MBRX | Moleculin Biotech, Inc. | 25.59M | 14.45% | 487,647 | - |
| 523 | EQ | Equillium, Inc. | 25.39M | 6.32% | 119,500 | 42.63M |
| 524 | VINC | Vincerx Pharma, Inc. | 25.23M | 13.46% | 280,318 | - |
| 525 | LUMO | Lumos Pharma, Inc. | 25.17M | 2.91% | 18,856 | 1.74M |
| 526 | NTBL | Notable Labs Inc. | 25.11M | -3.57% | 37,856 | - |
| 527 | ABIO | ARCA biopharma, Inc. | 24.50M | -0.58% | 47,860 | - |
| 528 | RNXT | RenovoRx, Inc. | 24.49M | 55.78% | 1,136,490 | - |
| 529 | PLUR | Pluri Inc. | 24.04M | -0.09% | 127,820 | 254.00K |
| 530 | TNXP | Tonix Pharmaceuticals Holding Corp. | 23.62M | -1.95% | 1,630,863 | 3.99M |
| 531 | ELEV | Elevation Oncology, Inc. | 22.78M | -1.63% | 212,490 | - |
| 532 | VRAX | Virax Biolabs Group Limited | 22.70M | -9.32% | 175,180 | 8.56K |
| 533 | OCEA | Ocean Biomedical, Inc. | 22.45M | -14.68% | 709,673 | - |
| 534 | LSTA | Lisata Therapeutics, Inc. | 22.22M | -2.85% | 17,687 | - |
| 535 | VIRX | Viracta Therapeutics, Inc. | 22.02M | -0.04% | 145,920 | - |
| 536 | PMN | ProMIS Neurosciences, Inc. | 21.72M | 4.55% | 39,817 | - |
| 537 | AIM | AIM ImmunoTech Inc. | 21.49M | -8.73% | 363,839 | 193.00K |
| 538 | TARA | Protara Therapeutics, Inc. | 21.31M | -1.83% | 78,106 | - |
| 539 | FRES | Fresh2 Group Ltd | 21.11M | 13.02% | 47,914 | 1.63M |
| 540 | NLSP | NLS Pharmaceutics AG | 21.04M | 16.60% | 205,672 | - |
| 541 | OCX | OncoCyte Corporation | 20.65M | - | 58,887 | -2.36M |
| 542 | APTO | Aptose Biosciences Inc. | 20.17M | 3.67% | 72,512 | - |
| 543 | MTEM | Molecular Templates, Inc. | 20.05M | -0.53% | 22,899 | 52.90M |
| 544 | GLTO | Galecto, Inc. | 19.52M | -7.69% | 276,334 | - |
| 545 | GYRE | Gyre Therapeutics Inc | 19.42M | -2.21% | 41,180 | - |
| 546 | SRZN | Surrozen, Inc. | 19.16M | 4.45% | 47,164 | 12.50M |
| 547 | PPBT | Purple Biotech Ltd. | 19.14M | -4.99% | 143,592 | - |
| 548 | EVAX | Evaxion Biotech A/S | 18.95M | -3.42% | 53,836 | - |
| 549 | ICU | SeaStar Medical Holding Corporation | 18.65M | 2.98% | 1,606,646 | - |
| 550 | PMCB | PharmaCyte Biotech, Inc. | 18.61M | -4.42% | 53,669 | - |
| 551 | NTRB | Nutriband Inc. | 18.17M | -5.31% | 34,445 | 2.09M |
| 552 | CNTX | Context Therapeutics Inc. | 18.04M | -1.74% | 55,848 | - |
| 553 | PIRS | Pieris Pharmaceuticals, Inc. | 17.99M | -2.52% | 298,188 | 47.36M |
| 554 | NRBO | NeuroBo Pharmaceuticals, Inc. | 17.93M | -6.42% | 57,662 | - |
| 555 | APRE | Aprea Therapeutics, Inc. | 17.56M | 28.42% | 116,788 | 569.16K |
| 556 | COCP | Cocrystal Pharma, Inc. | 17.52M | -1.59% | 21,723 | - |
| 557 | SNSE | Sensei Biotherapeutics, Inc. | 17.30M | -5.21% | 108,926 | - |
| 558 | ENTX | Entera Bio Ltd. | 17.29M | 8.95% | 401,175 | 14.00K |
| 559 | TCRT | Alaunos Therapeutics, Inc. | 17.01M | 2.02% | 7,544,371 | 15.00K |
| 560 | TFFP | TFF Pharmaceuticals, Inc. | 16.60M | -6.01% | 35,709 | 932.32K |
| 561 | AKTX | Akari Therapeutics, Plc | 16.53M | 4.00% | 856 | - |
| 562 | ORGS | Orgenesis Inc. | 15.96M | -0.26% | 108,397 | 27.75M |
| 563 | MAIA | MAIA Biotechnology, Inc. | 15.94M | -5.65% | 166,079 | - |
| 564 | ONTX | Onconova Therapeutics, Inc. | 15.66M | 0.23% | 117,507 | 226.00K |
| 565 | NCNA | NuCana plc | 15.62M | 1.13% | 155,476 | - |
| 566 | XLO | Xilio Therapeutics, Inc. | 15.14M | -3.51% | 96,709 | - |
| 567 | ALRN | Aileron Therapeutics, Inc. | 14.89M | -4.13% | 76,534 | - |
| 568 | LPCN | Lipocine Inc. | 14.83M | -1.76% | 18,373 | -3.07M |
| 569 | INDP | Indaptus Therapeutics, Inc. | 14.79M | 1.15% | 22,004 | - |
| 570 | AGE | AgeX Therapeutics, Inc. | 14.61M | -1.53% | 93,009 | 94.00K |
| 571 | EDSA | Edesa Biotech, Inc. | 14.46M | 1.78% | 34,826 | - |
| 572 | OGEN | Oragenics, Inc. | 14.46M | 4.77% | 26,315 | 37.65K |
| 573 | BCDA | BioCardia, Inc. | 14.36M | 1.40% | 173,106 | 570.00K |
| 574 | NRXS | NeurAxis, Inc. | 14.12M | 4.71% | 13,206 | 2.54M |
| 575 | HEPA | Hepion Pharmaceuticals, Inc. | 14.05M | -3.57% | 72,165 | - |
| 576 | VBIV | VBI Vaccines Inc. | 13.92M | -1.06% | 140,285 | 8.12M |
| 577 | DOMH | Dominari Holdings Inc. | 13.84M | 1.97% | 24,895 | 1.03M |
| 578 | GNPX | Genprex, Inc. | 13.67M | - | 580,821 | - |
| 579 | SEEL | Seelos Therapeutics, Inc. | 13.61M | -4.14% | 420,253 | 1.55M |
| 580 | BCLI | Brainstorm Cell Therapeutics Inc. | 13.37M | 3.33% | 1,577,633 | - |
| 581 | MYMD | MyMD Pharmaceuticals, Inc. | 13.17M | 4.44% | 13,970,645 | - |
| 582 | PHGE | BiomX Inc. | 13.15M | -3.28% | 217,062 | - |
| 583 | LEXX | Lexaria Bioscience Corp. | 12.85M | -2.34% | 131,866 | 226.21K |
| 584 | MBIO | Mustang Bio, Inc. | 12.44M | -0.74% | 70,201 | - |
| 585 | NNVC | NanoViricides, Inc. | 11.98M | -4.67% | 121,583 | - |
| 586 | SPRC | SciSparc Ltd. | 11.96M | -0.41% | 68,588 | 3.32M |
| 587 | IMRN | Immuron Limited | 11.65M | -1.32% | 3,405 | 1.24M |
| 588 | LABP | Landos Biopharma, Inc. | 11.41M | 5.17% | 6,248 | - |
| 589 | AZTR | Azitra, Inc. | 11.13M | -13.22% | 38,440 | 626.50K |
| 590 | VIRI | Virios Therapeutics, Inc. | 11.07M | -0.98% | 76,271 | - |
| 591 | BNOX | Bionomics Limited | 11.06M | -3.23% | 253,932 | 15.21K |
| 592 | ATHE | Alterity Therapeutics Limited | 10.98M | -0.40% | 16,256 | - |
| 593 | TRVN | Trevena, Inc. | 10.96M | 1.86% | 69,939 | 3.21M |
| 594 | NHWK | NightHawk Biosciences, Inc. | 10.89M | -10.33% | 192,608 | 2.23M |
| 595 | NRSN | NeuroSense Therapeutics Ltd. | 10.69M | 0.64% | 135,494 | - |
| 596 | GTBP | GT Biopharma, Inc. | 10.58M | -0.39% | 262,412 | - |
| 597 | KZIA | Kazia Therapeutics Limited | 10.39M | -0.54% | 123,260 | 15.86K |
| 598 | APM | Aptorum Group Limited | 10.21M | -1.27% | 6,428 | 1.20M |
| 599 | CANF | Can-Fite BioPharma Ltd. | 9.97M | 3.77% | 11,366 | 793.00K |
| 600 | EIGR | Eiger BioPharmaceuticals, Inc. | 9.96M | -15.66% | 649,533 | 14.67M |
| 601 | ONVO | Organovo Holdings, Inc. | 9.81M | -1.77% | 102,592 | 368.00K |
| 602 | BTTX | Better Therapeutics, Inc. | 9.72M | 4.84% | 341,387 | - |
| 603 | ERNA | Eterna Therapeutics Inc. | 9.71M | 0.84% | 17,729 | 51.00K |
| 604 | GOVX | GeoVax Labs, Inc. | 9.64M | 3.05% | 203,826 | - |
| 605 | CVKD | Cadrenal Therapeutics, Inc. | 9.63M | 8.33% | 125,231 | - |
| 606 | AIMD | Ainos, Inc. | 9.59M | - | 31,744 | 1.14M |
| 607 | ADXN | Addex Therapeutics Ltd | 9.20M | 3.42% | 7,867 | 2.24M |
| 608 | ARAV | Aravive, Inc. | 9.10M | -2.14% | 578,296 | 7.00M |
| 609 | AEZS | Aeterna Zentaris Inc. | 9.03M | -3.63% | 16,512 | 6.86M |
| 610 | ABVC | ABVC BioPharma, Inc. | 8.98M | -7.20% | 221,888 | 739.26K |
| 611 | VCNX | Vaccinex, Inc. | 8.31M | 0.36% | 78,539 | 795.00K |
| 612 | ADTX | Aditxt, Inc. | 8.28M | 37.55% | 27,697,418 | 749.48K |
| 613 | PCSA | Processa Pharmaceuticals, Inc. | 8.24M | -22.99% | 2,024,279 | - |
| 614 | BNTC | Benitec Biopharma Inc. | 8.23M | -4.00% | 18,767 | 75.00K |
| 615 | CYCN | Cyclerion Therapeutics, Inc. | 8.19M | -14.76% | 13,479 | 608.00K |
| 616 | BRTX | BioRestorative Therapies, Inc. | 8.19M | -4.92% | 22,335 | 130.20K |
| 617 | PSTV | Plus Therapeutics, Inc. | 7.92M | 2.95% | 73,728 | 3.75M |
| 618 | GRTX | Galera Therapeutics, Inc. | 7.91M | 1.68% | 773,000 | - |
| 619 | CNSP | CNS Pharmaceuticals, Inc. | 7.89M | 0.79% | 33,693 | - |
| 620 | SNGX | Soligenix, Inc. | 7.86M | 10.73% | 722,066 | 960.62K |
| 621 | IKT | Inhibikase Therapeutics, Inc. | 7.84M | 4.10% | 309,750 | 324.07K |
| 622 | KTTA | Pasithea Therapeutics Corp. | 7.71M | -5.13% | 267,120 | 240.71K |
| 623 | JAGX | Jaguar Health, Inc. | 7.68M | -6.49% | 4,891,178 | 10.72M |
| 624 | TOVX | Theriva Biologics, Inc. | 7.33M | -2.67% | 80,104 | - |
| 625 | ASLN | ASLAN Pharmaceuticals Limited | 7.10M | 4.67% | 239,388 | 12.00M |
| 626 | PULM | Pulmatrix, Inc. | 6.79M | -4.62% | 16,101 | 6.80M |
| 627 | TENX | Tenax Therapeutics, Inc. | 6.55M | -16.79% | 3,726,009 | - |
| 628 | BPTS | Biophytis S.A. | 6.52M | -7.81% | 18,644 | - |
| 629 | IMNN | Imunon, Inc. | 6.39M | 3.50% | 199,877 | 125.00K |
| 630 | CELZ | Creative Medical Technology Holdings, Inc. | 6.37M | -1.28% | 11,495 | 24.60K |
| 631 | ALZN | Alzamend Neuro, Inc. | 6.34M | -1.70% | 103,976 | - |
| 632 | CMMB | Chemomab Therapeutics Ltd. | 6.33M | -3.77% | 103,200 | - |
| 633 | PBLA | Panbela Therapeutics, Inc. | 6.27M | -6.63% | 680,731 | - |
| 634 | HOTH | Hoth Therapeutics, Inc. | 6.26M | -7.69% | 171,154 | - |
| 635 | TTNP | Titan Pharmaceuticals, Inc. | 6.21M | 25.00% | 258,822 | 306.00K |
| 636 | PYPD | PolyPid Ltd. | 6.21M | -0.52% | 7,006 | - |
| 637 | LIPO | Lipella Pharmaceuticals Inc. | 5.92M | 0.99% | 8,213 | 479.78K |
| 638 | FNCH | Finch Therapeutics Group, Inc. | 5.80M | -9.07% | 27,828 | 115.00K |
| 639 | BPTH | Bio-Path Holdings, Inc. | 5.72M | -2.32% | 119,580 | - |
| 640 | SNPX | Synaptogenix, Inc. | 5.54M | -5.79% | 145,193 | - |
| 641 | TCON | TRACON Pharmaceuticals, Inc. | 5.45M | -2.51% | 997,797 | 9.00M |
| 642 | PALI | Palisade Bio, Inc. | 5.44M | -9.77% | 418,351 | 250.00K |
| 643 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 5.34M | -1.42% | 86,380 | 147.81K |
| 644 | XBIO | Xenetic Biosciences, Inc. | 5.32M | -4.16% | 7,693 | 2.35M |
| 645 | LIXT | Lixte Biotechnology Holdings, Inc. | 5.29M | - | 4,991 | - |
| 646 | BCEL | Atreca, Inc. | 5.23M | - | 2,169,245 | - |
| 647 | XTLB | XTL Biopharmaceuticals Ltd. | 5.23M | 1.01% | 6,072 | - |
| 648 | MNPR | Monopar Therapeutics Inc. | 5.06M | -9.79% | 132,840 | - |
| 649 | XCUR | Exicure, Inc. | 5.02M | -1.66% | 47,357 | 23.79M |
| 650 | DRUG | Bright Minds Biosciences Inc. | 4.98M | -7.74% | 104,140 | - |
| 651 | CYTO | Altamira Therapeutics Ltd. | 4.93M | 7.41% | 1,258,882 | -902.13K |
| 652 | QNRX | Quoin Pharmaceuticals, Ltd. | 4.84M | -4.20% | 48,384 | - |
| 653 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.76M | -8.11% | 283,007 | -209.26K |
| 654 | CMND | Clearmind Medicine Inc. | 4.76M | 8.08% | 719,307 | - |
| 655 | SILO | Silo Pharma, Inc. | 4.48M | 1.41% | 112,788 | 72.10K |
| 656 | ARTL | Artelo Biosciences, Inc. | 4.46M | -0.18% | 14,059 | - |
| 657 | PTIX | Protagenic Therapeutics, Inc. | 4.39M | 6.76% | 12,922 | - |
| 658 | RNAZ | TransCode Therapeutics, Inc. | 4.14M | -3.68% | 849,433 | - |
| 659 | KPRX | Kiora Pharmaceuticals, Inc. | 4.02M | -5.05% | 53,967 | - |
| 660 | VRPX | Virpax Pharmaceuticals, Inc. | 3.75M | -3.29% | 153,257 | - |
| 661 | WINT | Windtree Therapeutics, Inc. | 3.70M | 0.48% | 453,926 | - |
| 662 | CING | Cingulate Inc. | 3.56M | -22.10% | 2,871,142 | - |
| 663 | APVO | Aptevo Therapeutics Inc. | 3.41M | -4.44% | 402,479 | - |
| 664 | ONCO | Onconetix Inc | 3.41M | -2.70% | 253,138 | - |
| 665 | ENSC | Ensysce Biosciences, Inc. | 3.33M | 3.92% | 65,296 | - |
| 666 | ALLR | Allarity Therapeutics, Inc. | 3.24M | 1.07% | 176,945 | - |
| 667 | THAR | Tharimmune Inc. | 3.17M | 2.00% | 6,050,770 | - |
| 668 | REVB | Revelation Biosciences, Inc. | 3.15M | -4.92% | 99,575 | - |
| 669 | ENVB | Enveric Biosciences, Inc. | 3.02M | -16.67% | 222,738 | - |
| 670 | QLGN | Qualigen Therapeutics, Inc. | 2.85M | -0.45% | 19,040 | 4.62M |
| 671 | FWBI | First Wave BioPharma, Inc. | 2.83M | -10.45% | 376,781 | - |
| 672 | SCNI | Scinai Immunotherapeutics Ltd. | 2.81M | -14.94% | 211,636 | - |
| 673 | NBSE | NeuBase Therapeutics, Inc. | 2.76M | 4.09% | 144,656 | - |
| 674 | SLRX | Salarius Pharmaceuticals, Inc. | 2.56M | 0.20% | 12,107 | - |
| 675 | NEXI | NexImmune, Inc. | 2.35M | 4.72% | 20,721 | - |
| 676 | NVIV | InVivo Therapeutics Holdings Corp. | 2.27M | -6.37% | 27,583 | - |
| 677 | ADIL | Adial Pharmaceuticals, Inc. | 2.27M | 5.08% | 1,179,835 | - |
| 678 | CYCC | Cyclacel Pharmaceuticals, Inc. | 2.25M | -5.99% | 213,692 | 389.00K |
| 679 | INM | InMed Pharmaceuticals Inc. | 2.19M | 9.91% | 325,982 | 4.72M |
| 680 | DRMA | Dermata Therapeutics, Inc. | 2.16M | 5.17% | 30,038 | - |
| 681 | ATNF | 180 Life Sciences Corp. | 2.14M | 1.18% | 351,852 | - |
| 682 | ATXI | Avenue Therapeutics, Inc. | 2.13M | -1.17% | 288,013 | - |
| 683 | IBIO | iBio, Inc. | 1.92M | -3.52% | 167,318 | 50.00K |
| 684 | BDRX | Biodexa Pharmaceuticals Plc | 1.86M | 3.47% | 58,246 | 377.22K |
| 685 | PHIO | Phio Pharmaceuticals Corp. | 1.86M | -0.52% | 64,783 | - |
| 686 | GRI | GRI Bio, Inc. | 1.74M | 1.05% | 284,722 | - |
| 687 | GLMD | Galmed Pharmaceuticals Ltd. | 1.73M | 2.27% | 80,385 | - |
| 688 | AMPE | Ampio Pharmaceuticals, Inc. | 1.71M | -13.14% | 141,429 | - |
| 689 | ZVSA | ZyVersa Therapeutics, Inc. | 1.48M | -4.96% | 274,168 | - |
| 690 | NBY | NovaBay Pharmaceuticals, Inc. | 1.33M | -3.91% | 1,322,412 | 14.64M |
| 691 | PXMD | PaxMedica, Inc. | 766.20K | -4.82% | 277,372 | - |
| 692 | KTRA | Kintara Therapeutics, Inc. | 574.57K | -12.12% | 123,840,728 | - |
| 693 | TCBP | TC Biopharm (Holdings) Plc | 109.86K | 9.31% | 766,154 | 3.61M |